What is Neuronetics's G&A?

Neuronetics (STIM) reported G&A of $13.05M in Q1 2026.

How has Neuronetics's G&A changed year-over-year?

Neuronetics's G&A decreased by 0.7% year-over-year, from $13.14M to $13.05M.

What is the long-term trend for Neuronetics's G&A?

Over 4 years (2021 to 2025), Neuronetics's G&A has grown at a 18.1% compound annual growth rate (CAGR), from $25.55M to $49.7M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Neuronetics STIM G&A

G&A at other companies

LBR

LB Pharmaceuticals Inc Common StockLBRX

$7.46M+148%

StereotaxisSTXS

$4.76M+5.9%

Neuropace, Inc.NPCE

$4.84M+19.7%

Myriad GeneticsMYGN

$62.2M-6.5%

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-59.6%

Enterprise value$162.64M-44.6%

P/S0.6×-1.4×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's G&A?: Neuronetics (STIM) reported G&A of $13.05M in Q1 2026.
How has Neuronetics's G&A changed year-over-year?: Neuronetics's G&A decreased by 0.7% year-over-year, from $13.14M to $13.05M.
What is the long-term trend for Neuronetics's G&A?: Over 4 years (2021 to 2025), Neuronetics's G&A has grown at a 18.1% compound annual growth rate (CAGR), from $25.55M to $49.7M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.